COVID-19 Novo Nordisk Information and Resources

We know this is an unprecedented time for everyone and we especially recognize that this serious health crisis could bring new concerns and challenges. As we navigate the COVID-19 crisis, Novo Nordisk is focusing on three key priorities:

  • Ensuring patients continue to get the medicines they need
  • Keeping our employees safe
  • Supporting the public health agenda


Employer Guide: The COVID-19 Crisis is Making the Management of Obesity More Important Than Ever

Read more about Novo Nordisk Actions and Contributions during COVID-19.

COVID-19 Novo Nordisk Information and Resources

Contact Information

For general inquiries: 1.800.727.6500

For our Diabetes Patient Assistance Program, affordability and NovoCare services: 1.844.NOVO4ME (844.668.6463) or visit

For Rare Bleeding Disorder services, please visit

If you’re a healthcare professional: NovoMedLink is your source for diabetes product samples and support during the Coronavirus outbreak. For growth hormone, please contact your local representative.